These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35733913)

  • 1. Carbapenem-resistant Enterobacterales and
    Karlowsky JA; Bouchillon SK; El Mahdy Kotb R; Mohamed N; Stone GG; Sahm DF
    JAC Antimicrob Resist; 2022 Jun; 4(3):dlac060. PubMed ID: 35733913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
    Piérard D; Stone GG
    BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017-2021.
    Wise MG; Karlowsky JA; Hackel MA; Harti MA; Ntshole BME; Njagua EN; Oladele R; Samuel C; Khan S; Wadula J; Lowman W; Lembede BW; Sahm DF
    J Glob Antimicrob Resist; 2023 Dec; 35():93-100. PubMed ID: 37709139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
    Karlowsky JA; Kazmierczak KM; Valente MLNF; Luengas EL; Baudrit M; Quintana A; Irani P; Stone GG; Sahm DF
    Braz J Infect Dis; 2021; 25(6):101647. PubMed ID: 34774471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftazidime/avibactam and comparators against carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa isolates collected globally between 2016 and 2018.
    Kiratisin P; Kazmierczak K; Stone GG
    J Glob Antimicrob Resist; 2021 Dec; 27():132-141. PubMed ID: 34478880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020.
    Karlowsky JA; Bouchillon SK; Benaouda A; Soraa N; Zerouali K; Mohamed N; Alami T; Sahm DF
    J Glob Antimicrob Resist; 2022 Sep; 30():23-30. PubMed ID: 35447385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020.
    Karlowsky JA; Lob SH; Siddiqui F; Pavia J; DeRyke CA; Young K; Motyl MR; Sahm DF
    Braz J Infect Dis; 2023; 27(3):102775. PubMed ID: 37169345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ceftazidime-avibactam and comparators against Gram-negative bacterial isolates collected in the Asia-Pacific region as part of the INFORM program (2015-2017).
    Ko WC; Stone GG
    Ann Clin Microbiol Antimicrob; 2020 Apr; 19(1):14. PubMed ID: 32238155
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wise MG; Karlowsky JA; Hackel MA; Takemura M; Yamano Y; Echols R; Sahm DF
    Microb Drug Resist; 2023 Aug; 29(8):360-370. PubMed ID: 37253158
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Karlowsky JA; Bouchillon SK; El Mahdy Kotb R; Mohamed N; Stone GG; Sahm DF
    JAC Antimicrob Resist; 2021 Jun; 3(2):dlab067. PubMed ID: 34223129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Malaysia: Results from the ATLAS Programme, 2013 to 2019.
    Tuan Soh TS; Salvinder S; Chen VSY
    Med J Malaysia; 2022 Mar; 77(2):174-184. PubMed ID: 35338624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of carbapenemase genes among carbapenem-nonsusceptible
    Castanheira M; Deshpande LM; Mendes RE; Doyle TB; Sader HS
    JAC Antimicrob Resist; 2022 Oct; 4(5):dlac098. PubMed ID: 36196444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020.
    Karlowsky JA; Lob SH; Chen WT; DeRyke CA; Siddiqui F; Young K; Motyl MR; Sahm DF
    Int J Antimicrob Agents; 2023 Sep; 62(3):106900. PubMed ID: 37354921
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible
    Kazmierczak KM; Karlowsky JA; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0200020. PubMed ID: 33972241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017-2020.
    Karlowsky JA; Lob SH; Khan TK; Chen WT; Woo PCY; Seto WH; Ip M; Leung SWM; Wong QW; Chau RWY; DeRyke CA; Young K; Motyl MR; Sahm DF
    J Glob Antimicrob Resist; 2023 Jun; 33():260-266. PubMed ID: 37086892
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftazidime-avibactam against Gram-negative isolates collected in 18 European countries, 2015-2017.
    Stone GG; Seifert H; Nord CE
    Int J Antimicrob Agents; 2020 Sep; 56(3):106045. PubMed ID: 32522673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftazidime/avibactam and comparators against Gram-negative bacterial isolates collected from Latin American centres between 2015 and 2017.
    Stone GG; Ponce-de-Leon A
    J Antimicrob Chemother; 2020 Jul; 75(7):1859-1873. PubMed ID: 32277820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013-17.
    Kazmierczak KM; de Jonge BLM; Stone GG; Sahm DF
    J Antimicrob Chemother; 2020 May; 75(5):1165-1173. PubMed ID: 32040168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.